Salvatore Petta
Salvatore Petta
Ricercatore di Gastroenterologia, Universitā di Palermo
Verified email at unipa.it - Homepage
TitleCited byYear
Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species
MG Perrelli, P Pagliaro, C Penna
World journal of cardiology 3 (6), 186, 2011
920*2011
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C
S Petta, C Cammā, C Scazzone, C Tripodo, V Di Marco, A Bono, D Cabibi, ...
Hepatology 51 (4), 1158-1167, 2010
4422010
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis
E Villa, C Cammā, M Marietta, M Luongo, R Critelli, S Colopi, C Tata, ...
Gastroenterology 143 (5), 1253-1260. e4, 2012
4332012
Non-alcoholic fatty liver disease pathogenesis: the present and the future
S Petta, C Muratore, A Craxi
Digestive and Liver Disease 41 (9), 615-625, 2009
3272009
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
2292015
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C
L Rizzo, V Calvaruso, B Cacopardo, N Alessi, M Attanasio, S Petta, ...
The American journal of gastroenterology 106 (12), 2112, 2011
2142011
EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version)
CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ...
Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017
2092017
Statin use and non-alcoholic steatohepatitis in at risk individuals
P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ...
Journal of hepatology 63 (3), 705-712, 2015
1682015
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection
S Petta, C Camma, V Di Marco, N Alessi, D Cabibi, R Caldarella, A Licata, ...
The American journal of gastroenterology 103 (5), 1136, 2008
1672008
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ...
Gastroenterology 150 (5), 1219-1230. e6, 2016
1492016
Cost‐effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
C Cammā, S Petta, M Enea, R Bruno, F Bronte, V Capursi, A Cicchetti, ...
Hepatology 56 (3), 850-860, 2012
1352012
Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies
S Petta, M Maida, FS Macaluso, M Barbara, A Licata, A Craxė, C Cammā
Gastroenterology 150 (1), 145-155. e4, 2016
1332016
Hyperuricemia is associated with histological liver damage in patients with non‐alcoholic fatty liver disease
S Petta, C Camma, D Cabibi, V Di Marco, A Craxi
Alimentary pharmacology & therapeutics 34 (7), 757-766, 2011
1192011
Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice
G Marchesini, S Petta, R Dalle Grave
Hepatology 63 (6), 2032-2043, 2016
1142016
Reliability of liver stiffness measurement in non‐alcoholic fatty liver disease: the effects of body mass index
S Petta, V Di Marco, C Cammā, G Butera, D Cabibi, A Craxi
Alimentary pharmacology & therapeutics 33 (12), 1350-1360, 2011
1102011
Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations
S Petta, D Torres, G Fazio, C Cammā, D Cabibi, V Di Marco, A Licata, ...
Hepatology 55 (5), 1317-1323, 2012
1082012
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C
E Villa, A Karampatou, C Cammā, A Di Leo, M Luongo, A Ferrari, S Petta, ...
Gastroenterology 140 (3), 818-829. e2, 2011
1032011
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ...
Digestive and Liver Disease 49 (5), 471-483, 2017
982017
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease
S Petta, M Maida, FS Macaluso, V Di Marco, C Cammā, D Cabibi, A Craxė
Hepatology 62 (4), 1101-1110, 2015
962015
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C
O Lo Iacono, G Venezia, S Petta, C Mineo, S De Lisi, V Di Marco, ...
Alimentary pharmacology & therapeutics 25 (10), 1181-1191, 2007
962007
The system can't perform the operation now. Try again later.
Articles 1–20